WallStSmart
TECX

Tectonic Therapeutic, Inc.

NASDAQ: TECX · HEALTHCARE · BIOTECHNOLOGY

$27.97
+3.32% today

Updated 2026-04-30

Market cap
$512.68M
P/E ratio
P/S ratio
EPS (TTM)
$-4.05
Dividend yield
52W range
$14 – $36
Volume
0.3M

Tectonic Therapeutic, Inc. (TECX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2016201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$45000.00$380000.00$850000.00$1.21M$1.40M$4.17M$617000.00$1.65M
Gross profit$-45000.00$-380000.00$-850000.00$-1.21M$-1.40M$-4.17M$-617000.00$-1.65M
Gross margin
R&D$2.66M$15.19M$35.09M$54.97M$86.03M$10.98M$25.65M$36.97M$41.36M$63.49M
SG&A$4.63M$7.18M$7.68M$16.65M$20.55M
Operating income$-4.63M$-18.39M$-46.24M$-75.81M$-120.23M$-15.61M$-32.83M$-44.65M$-58.02M$-84.04M
Operating margin
EBITDA$-4.66M$-18.60M$-45.98M$-72.11M$-118.50M$-8.12M$-31.03M$-41.19M$-56.23M$-71.48M
EBITDA margin
EBIT$-4.63M$-18.65M$-46.36M$-72.97M$-119.71M$-8.48M$-32.04M$-42.67M$-57.88M$-72.86M
Interest expense$224000.00$144000.00$152000.00$107000.00$63000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-4.66M$-18.65M$-46.36M$-72.97M$-119.71M$-8.93M$-32.18M$-42.82M$-57.98M$-74.15M
Net income growth (YoY)-299.8%-148.6%-57.4%-64.1%+92.5%-260.5%-33.1%-35.4%-27.9%
Profit margin